Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
Diabetes reduces survival after SAVR, but not TAVR
"TAVR has been associated with better valve hemodynamics and a lower risk of structural valve deterioration over time compared with SAVR," researchers wrote. "This benefit may be particularly relevant for diabetes patients who face higher risks of vascular complications."
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
Brain changes related to Huntington's evident on imaging decades before symptoms emerge
Experts hope their findings offer valuable insights that one day lead to improved interventions aimed at preserving brain function in patients with Huntington's.
Medtronic heart rhythm technologies on full display at AF Symposium 2025
Cardiologists shared updated data on Medtronic's ICM and PFA offerings during AF Symposium 2025 in Boston.

However, the two treatment options were associated with similar rates of long-term bleeding and ischemic events.

Two trainees with New York-Presbyterian Hospital shared their experiences in Clinical Radiology.

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests.

Almost half the 540-participant cohort is already using at least one form of AI.

The study's authors looked at nearly 3,000 clinical trials related to the ongoing pandemic.

Nostrum Laboratories is at the center of this latest voluntary recall.

No procedure-related deaths were reported, and an absolute LVEF improvement of more than 5% was present in nearly 49% of patients.

The patch harvests energy from each heartbeat, allowing it to operate with no external power source.